Advertisement

Application of Targeted Next Generation Sequencing Technology in the Diagnosis of Mycobacterium Tuberculosis and First Line Drugs Resistance Directly from Cell-free DNA of Bronchoalveolar Lavage Fluid

Published:January 24, 2023DOI:https://doi.org/10.1016/j.jinf.2023.01.031
      Dear editor,
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Infection
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. Global tuberculosis report 2022.
        World Health Organization, Geneva2022 (Licence: CC BY-NC-SA 3.0 IGO)
        • Calderwood CJ
        • Reeve BW
        • Mann T
        • Palmer Z
        • Nyawo G
        • Mishra H
        • Ndlangalavu G
        • Abubakar I
        • Noursadeghi M
        • Theron G
        • Gupta RK
        Clinical utility of C-reactive protein-based triage for presumptive pulmonary tuberculosis in South African adults.
        J Infect. 2023; 86: 24-32
        • Huang F
        • van den Hof S
        • Qu Y
        • Li Y
        • Zhang H
        • Wang L
        • Sun M
        • Lu W
        • Hou S
        • Zhang T
        • Huan S
        • Chin DP
        • Cobelens F.
        Added Value of Comprehensive Program to Provide Universal Access to Care for Sputum Smear-Negative Drug-Resistant Tuberculosis.
        China. Emerg Infect Dis. 2019; 25: 1289-1296
        • Zaw MT
        • Emran NA
        • Lin Z.
        Mutations inside rifampicin-resistance determining region of rpoB gene associated with rifampicin-resistance in Mycobacterium tuberculosis.
        J Infect Public Health. 2018; 11: 605-610
        • Wu X
        • Tan G
        • Yang J
        • Guo Y
        • Huang C
        • Sha W
        • Yu F
        Prediction of Mycobacterium tuberculosis drug resistance by nucleotide MALDI-TOF-MS.
        Int J Infect Dis. 2022; 121: 47-54
        • Riviere E
        • Whitfield MG
        • Nelen J
        • Heupink TH
        • Van Rie A.
        Identifying isoniazid resistance markers to guide inclusion of high-dose isoniazid in tuberculosis treatment regimens.
        Clin Microbiol Infect. 2020; 26: 1332-1337
        • Guo S
        • Chongsuvivatwong V
        • Lei S.
        Comparison on Major Gene Mutations Related to Rifampicin and Isoniazid Resistance between Beijing and Non-Beijing Strains of Mycobacterium tuberculosis: A Systematic Review and Bayesian Meta-Analysis.
        Genes (Basel). 2022; : 13
        • He P
        • Wang J
        • Ke R
        • Zhang W
        • Ning P
        • Zhang D
        • Yang X
        • Shi H
        • Fang P
        • Ming Z
        • Li W
        • Zhang J
        • Dong X
        • Liu Y
        • Zhou J
        • Xia H
        • Yang S
        Comparison of metagenomic next-generation sequencing using cell-free DNA and whole-cell DNA for the diagnoses of pulmonary infections.
        Front Cell Infect Microbiol. 2022; 121042945
        • Casadevall A
        • Fang FC.
        The intracellular pathogen concept.
        Mol Microbiol. 2020; 113: 541-545
        • Yu SC
        • Lee SW
        • Jiang P
        • Leung TY
        • Chan KC
        • Chiu RW
        • Lo YM.
        High-resolution profiling of fetal DNA clearance from maternal plasma by massively parallel sequencing.
        Clin Chem. 2013; 59: 1228-1237